Tags: DLBCLDiffuse Large B Cell LymphomaBispecific AntibodiesDLBCL Trialstoxicity management
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 2 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 3 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Year in Review: Follicular Lymphoma - 12 months ago Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? - about 1 year ago | |
| 4 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Positive Results for Odronextamab in Relapsed/Refractory DLBCL - 11 months ago | |
| 5 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
| 6 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 8 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 11 months ago Non-Covalent BTK Inhibitor Approved for CLL - 12 months ago | |
| 7 | Judy George MedPage Today Medical reporter, writer. | ||
| 8 | Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom | ||
| 9 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | Patients With CLL Present Heterogeneously - 9 months ago | |
| 10 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | Advancing Treatment Selection in CLL Management - 9 months ago |